These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 24029564
1. [The compared study in detecting the recurrence and metastases of breast cancer patients post treatment between (18)F-FDG PET/CT and conventional workup]. Zhang WG, Wang GH, Zhang WD, Fan W, Li J. Zhonghua Yi Xue Za Zhi; 2013 May 21; 93(19):1446-9. PubMed ID: 24029564 [Abstract] [Full Text] [Related]
4. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma. Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G. Nucl Med Commun; 2012 Jun 21; 33(6):591-6. PubMed ID: 22334135 [Abstract] [Full Text] [Related]
5. The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques. Aukema TS, Rutgers EJ, Vogel WV, Teertstra HJ, Oldenburg HS, Vrancken Peeters MT, Wesseling J, Russell NS, Valdés Olmos RA. Eur J Surg Oncol; 2010 Apr 21; 36(4):387-92. PubMed ID: 19962268 [Abstract] [Full Text] [Related]
7. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma]. Wang GH, Lau EW, Shakher R, Binns DS, Hogg A, Drummond E, Hicks RJ. Ai Zheng; 2007 Jun 21; 26(6):638-42. PubMed ID: 17562272 [Abstract] [Full Text] [Related]
8. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma. Park JW, Jo MK, Lee HM. BJU Int; 2009 Mar 21; 103(5):615-9. PubMed ID: 19007371 [Abstract] [Full Text] [Related]
11. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited. Zhang X, Wu F, Han P. Hell J Nucl Med; 2014 Mar 21; 17(3):177-83. PubMed ID: 25526754 [Abstract] [Full Text] [Related]
12. [The role of 18F-FDG SPECT-CT in detecting recurrence and metastases in breast cancer patients with elevated tumor markers]. Xing Y, Zhao JH, Wang TS, Qiao WL, Che WJ. Zhonghua Zhong Liu Za Zhi; 2009 Feb 21; 31(2):129-33. PubMed ID: 19538891 [Abstract] [Full Text] [Related]
19. Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients. Jung NY, Yoo IR, Kang BJ, Kim SH, Chae BJ, Seo YY. Breast Cancer; 2016 Jan 01; 23(1):141-148. PubMed ID: 24872087 [Abstract] [Full Text] [Related]
20. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies. Nakajo M, Nakajo M, Jinguji M, Tani A, Kajiya Y, Tanabe H, Fukukura Y, Nakabeppu Y, Koriyama C. Radiology; 2013 Jun 01; 267(3):891-901. PubMed ID: 23468571 [Abstract] [Full Text] [Related] Page: [Next] [New Search]